Trump Says U.S. Visas Can Be Denied to Fat People From Now On
New State Department guidance encourages embassies and consulates to deny visas to people with obesity or other health issues.

President Trump is rejecting visas for fat people.
The Trump administration has ordered visa officers to deny immigrants who are obese or have certain health issues, in yet another instance of the president’s strange obsession with fat people.
A Thursday directive from the State Department, sent to embassies and consulates around the world, indicates that people applying for visas to the United States may be rejected if they have certain medical conditions, on the grounds that they could take up domestic health care resources.
“You must consider an applicant’s health,” the cable read. “Certain medical conditions—including, but not limited to, cardiovascular diseases, respiratory diseases, cancers, diabetes, metabolic diseases, neurological diseases, and mental health conditions—can require hundreds of thousands of dollars’ worth of care.”
The announcement then goes on to mention obesity, stating that it can be connected to asthma, sleep apnea, and high blood pressure.
“All of these can require expensive, long-term care,” the cable continues. “Does the applicant have adequate financial resources to cover the costs of such care over his entire expected lifespan without seeking public cash assistance or long-term institutionalization at government expense?”
Denying fat people from the U.S. because they might end up having health issues is incredibly broad, cruel, and unusual. Visa applicants are already subjected to health screenings for infectious diseases like tuberculosis and are required to have various vaccinations.
“Taking into consideration one’s diabetic history or heart health history—that’s quite expansive,” immigration lawyer Sophia Genovese told the Los Angeles Times. “There is a degree of this assessment already, just not quite expansive as opining over, ‘What if someone goes into diabetic shock?’ If this change is going to happen immediately, that’s obviously going to cause a myriad of issues when people are going into their consular interviews.”
This announcement comes just one day after Trump announced his “fat shot” deal with two pharmaceutical companies to lower the cost of popular weight-loss drugs Ozempic and Zepbound to around $150 per month (they currently cost around $350 per month).
Trump also took time out of Thursday’s announcement to reveal exactly who was taking the weight-loss drug, outing longtime comms staffer and attack dog Steven Cheung.
“Where’s Steve? Is he here? Head of public relations for the White House? He’s taking it.”








